You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

CARBIDOPA AND LEVODOPA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Carbidopa And Levodopa, and when can generic versions of Carbidopa And Levodopa launch?

Carbidopa And Levodopa is a drug marketed by Accord Hlthcare, Alembic, Apotex, Impax Labs, Kv Pharm, Mylan, Sciegen Pharms Inc, Sun Pharm Inds, Rising, Sun Pharm, Actavis Elizabeth, Ani Pharms, Apotex Inc, Aurobindo Pharma Ltd, Dr Reddys Labs Sa, Rubicon, SCS, Watson Labs, and Zydus Pharms. and is included in twenty-seven NDAs.

The generic ingredient in CARBIDOPA AND LEVODOPA is carbidopa; levodopa. There are eighteen drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the carbidopa; levodopa profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Carbidopa And Levodopa

A generic version of CARBIDOPA AND LEVODOPA was approved as carbidopa; levodopa by DR REDDYS LABS SA on August 28th, 1992.

  Try a Trial

Drug patent expirations by year for CARBIDOPA AND LEVODOPA
Drug Prices for CARBIDOPA AND LEVODOPA

See drug prices for CARBIDOPA AND LEVODOPA

Recent Clinical Trials for CARBIDOPA AND LEVODOPA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Bronx VA Medical CenterPhase 1
VistaGen Therapeutics, Inc.Phase 2
University of MinnesotaEarly Phase 1

See all CARBIDOPA AND LEVODOPA clinical trials

Pharmacology for CARBIDOPA AND LEVODOPA
Anatomical Therapeutic Chemical (ATC) Classes for CARBIDOPA AND LEVODOPA

US Patents and Regulatory Information for CARBIDOPA AND LEVODOPA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET;ORAL 090324-002 Sep 28, 2009 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Apotex Inc CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET;ORAL 077120-002 Jun 2, 2008 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Scs CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET;ORAL 074080-001 Mar 25, 1994 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Zydus Pharms CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET;ORAL 215999-003 Apr 4, 2023 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Rubicon CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET;ORAL 216505-003 Sep 21, 2022 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Scs CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET;ORAL 074080-002 Mar 25, 1994 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Watson Labs CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET;ORAL 073381-001 Sep 28, 1993 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

EU/EMA Drug Approvals for CARBIDOPA AND LEVODOPA

Company Drugname Inn Product Number / Indication Status Generic Biosimilar Orphan Marketing Authorisation Marketing Refusal
Amneal Pharma Europe Ltd Numient levodopa, carbidopa EMEA/H/C/002611
Symptomatic treatment of adult patients with Parkinson’s disease
Withdrawn no no no 2015-11-19
>Company >Drugname >Inn >Product Number / Indication >Status >Generic >Biosimilar >Orphan >Marketing Authorisation >Marketing Refusal

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.